Sun Pharma shares drop after U.S. FDA inspection
U.S. FDA inspected Sun Pharma’s facility in Baska, Gujarat, from September 8 to 19. File | Photo Credit: Reuters Shares of Sun Pharmaceutical Industries closed 2.77% lower on Thursday (December 18, 2025) at ₹1,745.35 apiece on the BSE after the U.S. Food and Drug Administration (U.S. FDA) classified the company’s facility in Baska, Gujarat, as […]
Continue Reading
